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Heparin, known for its anticoagulant activity, is commonly used in catheter locks. Staphylococcus aureus, a
versatile human and animal pathogen, is commonly associated with catheter-related bloodstream infections
and has evolved a number of mechanisms through which it adheres to biotic and abiotic surfaces. We
demonstrate that heparin increased biofilm formation by several S. aureus strains. Surface coverage and the
kinetics of biofilm formation were stimulated, but primary attachment to the surface was not affected. Heparin
increased S. aureus cell-cell interactions in a protein synthesis-dependent manner. The addition of heparin
rescued biofilm formation of hla, ica, and sarA mutants. Our data further suggest that heparin stimulation of
biofilm formation occurs neither through an increase in sigB activity nor through an increase in polysaccharide
intracellular adhesin levels. These finding suggests that heparin stimulates S. aureus biofilm formation via a
novel pathway.
Heparin, a heterogeneous glycosaminoglycan, is commonly
used as an anticoagulant in catheter lock solutions. Heparin
and heparan sulfate are closely related compounds, the latter
found in the extracellular matrix on the surface of most mam-
malian cells (30). Several pathogens utilize heparin and other
glycosaminoglycans to adhere to and invade mammalian cells
(13–15, 19, 26, 50, 61).
Staphylococcus aureus is an important pathogen, particularly
in hospital settings, where it is a major source of life-threaten-
ing bloodstream infections. S. aureus is well adapted to the
human host and has a large number of factors that enable it to
adhere to specific host substrates, evade host defenses, and
resist antibiotic therapy (17, 23, 28, 31, 47, 49). One way in
which bacteria become resistant to antibiotics and host de-
fenses is through biofilm formation (62).
S. aureus adheres proficiently to abiotic surfaces as well as
biotic ones and is a problem in medical situations where im-
plants, such as indwelling catheters and prosthetic joints, are
employed (51). Catheter infections are surprisingly ubiquitous.
One group reported the observation that bacterial biofilms
were present on all used catheters they inspected by electron
microscopy (21). S. aureus is the infectious agent in the most
severe and costly episodes of catheter-related sepsis (1). It is
also associated with biofilm-related diseases such as infectious
arthritis, endocarditis, and cystic fibrosis (11, 51, 54, 60).
Because of the high rates of catheter colonization and the
common use of heparin in catheters, we questioned whether
heparin might influence S. aureus biofilm potential. Here we
characterized the phenotypic effects of heparin on S. aureus
biofilm formation. A number of genes have been linked to both
biofilm formation and disease, including hla, ica, sarA, and sigB
(2, 4, 8, 63, 66). We explore whether these genes are important
for biofilm stimulation by heparin.
MATERIALS AND METHODS
Strains and media. Staphylococcus aureus strains were grown in tryptic soy
broth (TSB) or on tryptic soy agar (TSA). For all phenotypic assays we use 66%
TSB plus 0.2% glucose, as this medium promotes robust biofilm formation (data
not shown) (20 g/liter of Difco Bacto tryptic soy broth, Becton Dickinson, Sparks,
MD). In this report 66% TSB is written as TSB. Strain MZ100 was used as a
wild-type strain unless otherwise noted. MZ100 was a gift from Microbia Inc.
(Cambridge, MA) and was made as RN6390, but we found that it made more
robust biofilms (36). Escherichia coli strains were grown in lysogeny broth (LB)
(5). Ampicillin was used at a concentration of 100 g/ml, chloramphenicol at 10
g/ml, kanamycin at 20 g/ml, tetracycline at 5 to 10 g/ml, and erythromycin at
5 g/ml. S. aureus strain RN4220 was used as a plasmid acceptor strain. Bacte-
riophages 80- and 11 were used to transduce mutations between strains.
Genetic manipulations. The ica operon (icaADBC) was replaced in MZ100 by
a tetracycline resistance cassette using the protocol of Crampton et al. (12).
Candidates were screened with PCR and tested for polysaccharide intercellular
adhesin (PIA) expression. Transduction of hla::ermC, sigB::ermC, sarA::aph3A,
and agr::tetM into MZ100 by bacteriophages 80- and 11 were performed using
published protocols and were verified by PCR and or Southern blot analysis (58).
Plasmid construction. Plasmid pALC2201 was created by ligating the promot-
erless gfpuvr gene into the HincII and PstI sites of pSK236 and the asp23 pro-
moter upstream of the gfpuvr in the EcoRI site. gfpuvr was made by the introduc-
tion of an S65T mutation into gfpuv (Clontech, Palo Alto, CA), shifting the
excitation maximum from 395 to 488 nm.
pALC2111 features dsred under the transcriptional control of the strong
RNAIII promoter. gfpuvr from plasmid pALC1743 was removed by digestion with
XbaI and PstI, and replaced with dsred from pDsRed (Clontech, San Jose, CA)
amplified with the sarA ribosome binding site engineered into the primers (2).
Growth curves. MZ100 cells were removed from a 80°C frozen stock and
streaked to single colonies on a TSA plate incubated overnight at 37°C. Cells
from three single colonies were inoculated into 5 ml of TSB broth and incubated
overnight at 37°C with aeration. After a 14 to 16 h incubation, each culture was
subcultured (1:1,000) into four test tubes, two with 5 ml of TSB plus 0.2% glucose
plus saline (10% vol/vol) and two with 5 ml of TSB plus 0.2% glucose plus
sodium heparin (10% vol/vol; a final concentration of 1,000 U/ml). Optical
density readings were obtained at 600 nm with a Spectronic 20Dplus (Spectronic
Instruments Inc., Rochester, NY), after cultures had been sonicated to disasso-
ciate cell-cell interactions that could potentially underestimate optical density
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readings; 1:10 and 1:100 dilutions were measured at later time points in order to
remain within the linear range of the spectrophotometer.
Microtiter plate biofilm assay. Overnight cultures of cells were normalized by
optical density, then diluted 1:50 into TSB plus 0.2% glucose with either sodium
heparin 10% volume/volume (1,000 U/ml; heparin sodium, NDC 63323-542-01,
American Pharmaceutical Partners, Inc., Schaumburg, IL) or saline (Abbott
Labs, Abbott Park, IL), 10% vol/vol, or other concentrations when specified. This
heparin solution contains two preservatives, methylparaben (0.15% vol/vol) and
propylparaben (0.015% vol/vol). These compounds were tested individually for
an effect on biofilm formation and we noted that at the concentration found in
heparin preparations (NDC 63323-542-01) propylparaben has a slight inhibitory
effect, while methylparaben has no apparent effect on biofilm formation (data
not shown). Additional heparin compounds were tested at 5.9 mg/ml (1,000 U/ml
for the heparins) including sodium heparin (Sigma H-1027 and H-9399; Sigma-
Aldrich, St. Louis, MO) ammonium heparin (H-6279), heparan sulfate (H-7640),
dextran sulfate (D-4911), chondroitin B (C-3788), and chondritin C (C-4384).
When indicated, chloramphenicol was added to 10 g/ml.
To assess biofilm formation, cultures were added to tissue culture-treated,
96-well polystyrene microtiter dishes (Costar 3595, Corning Inc., Corning, NY)
incubated in a closed, humidified plastic container for the indicated period of
time, then assayed for biofilm formation using a modified version of the Chris-
tenson plate assay using changes noted by Caiazza (8, 10). Photographs of the
inverted plate were taken with a digital camera (Nikon 990, Nikon, Mellvile, NY)
and then crystal violet was solubilized using 30% glacial acetic acid for 15 min.
Relative biofilm formation was assayed by reading optical density at 550 nm
using a Vmax kinetic microplate reader (Molecular Devices, Sunnyvale, CA).
Cell surface/primary attachment assays. Attachment of cells to polystyrene
was assessed as follows. Optical density-normalized overnight cultures of cells
grown in TSB were sonicated (model VC 505 equipped with a 3-mm stepped
microtip, Sonics and Materials Inc., Newton, CT) to minimize preexisting cell-
cell interactions. These cultures were diluted 1:50 into TSB plus 0.2% glucose
with either sodium heparin (1,000 U/ml final) or saline added to 10% vol/vol, and
then 0.5 ml of each sample was added to polystyrene 24-well plates (Costar 3624,
Corning Inc., Corning, NY). Plates were placed at 37°C without shaking. At
designated times nonadherent cells and medium were removed by aspiration
followed by 10 washes of the well with 1 ml of phosphate-buffered saline (PBS);
0.5 ml of PBS was added to the wells and attached cells were observed micro-
scopically. The same area of these 24-well plates was assessed in all treatments,
as only the centers of each well are sufficiently flat and optically clear for
microscopic analysis. Digital images of several fields were taken and later
counted for the number and type of adherent foci. Surface coverage was deter-
mined using Kodak 1D image analysis software (Kodak Inc., Rochester, NY).
Adherence to silicone elastomer. A 1-mm-thick sheet of silicone elastomer was
acquired from Goodfellow Cambridge Limited (LS269875, Huntingdon, En-
gland). Coupons (1/8-in. diameter) were acquired using a hole punch (FSK-2351,
Fiskars Inc., Madison, WI) and three were glued to the bottom of a well in a
24-well Costar dish with silicone sealant (Super Siliconee sealant 08661, 3M Inc,
St. Paul, MN). TSB plus 0.2% glucose and cells were added as with the microtiter
dish assay, except that 0.5 ml was added per well. Cells were incubated with the
coupons for 24 h and then were washed five times with sterile dH20, stained with
crystal violet, washed 3 times with sterile distilled H2O and allowed to dry
overnight. Individual crystal violet-stained coupons were then moved to individ-
ual wells of a 96-well plate containing 0.125 ml of 30% glacial acetic acid for 15
min; 0.1-ml aliquots of solubilized crystal violet were then moved to 96-well
dishes and A550 readings were determined as noted above.
Cell-cell interactions. The adherence of cells to one another was determined
using conditions identical to those for the cell surface experiments noted above,
except that samples of stationary planktonic cultures were removed and observed
directly with phase microscopy at various time points. Digital images of several
fields were tallied for the number and type of foci (clustered or unclustered). For
the protein synthesis inhibition experiment, a logarithmic culture of MZ100
grown in TSB was treated as above except that chloramphenicol (30 g/ml) was
added to inhibit protein synthesis. A double inoculum of cells was added at the
onset of the experiment to cultures exposed to chloramphenicol to control for the
difference in cell number that could affect the frequency of cell-interactions. At
180 min, planktonic samples from four wells per condition were assessed micro-
scopically for cell-cell interactions.
Microscopy. Phase-contrast and epifluorescent microscopy was performed
with a model DM IRBE inverted microscope (Leica Microsystems, Wetzlar,
Germany) with an attached charge-coupled device camera (model Orca C4742-5,
Hamamatsu, Hamamatsu City, Japan) and analyzed with Open Lab 4.0.2 soft-
ware (Improvision, Coventry, England). Cells in biofilms were stained with
Syto-9, a fluorescent nucleic acid stain (Molecular Probes, Eugene, Oregon) by
adding 1 l of Syto-9 per 1 ml PBS to biofilms, incubating for 30 min, followed
by washing several times with PBS. Biofilms were stained with calcofluor (fluo-
rescent brightener 28, F-3543 Sigma-Aldrich, St. Louis, MO) using the protocol
of Hamon et al. (24).
Scanning electron microscopy was performed as reported (33), except that
biofilms were allowed to form on a polyvinylchloride plastic coverslip (12 by 22
mm; Fisher Scientific, Pittsburgh, PA) that was placed in the bottom of a six-well
polystyrene cell culture dish (Falcon 35-3046, Becton Dickinson and Company,
Franklin Lakes, NJ). One corner of the coverslip was bent for orientation pur-
poses and to facilitate the use of forceps. The biofilm-coated coverslips were
washed, dipped 15 times into PBS to remove nonadherent cells, and then fixed
and prepared for scanning electron microscopy analysis as reported (33).
Polysaccharide adhesin levels. Polysaccharide adhesin levels were assessed as
previously described (12). Antiserum was a kind gift from G. B. Pier.
Sigma B activity. The levels of the sigma B-dependent promoter asp23 were
determined indirectly using a green fluorescent protein (GFP) reporter construct
as has been previously described (56).
Statistical analysis. P values were determined using Student’s t test with Excel
software. Error bars are shown as one standard deviation.
RESULTS
Heparin stimulates S. aureus biofilm formation in vitro. The
widespread use of sodium heparin as a catheter-lock solution
led us to test whether this compound has an impact upon the
adherence of S. aureus to abiotic surfaces. S. aureus strain
MZ100, a laboratory wild-type strain, was grown overnight in
TSB, then diluted into TSB plus 0.2% glucose with the addi-
tion of serial dilutions of sodium heparin, and allowed to form
a biofilm for 16 h in a 96-well polystyrene microtiter plate.
Nonadherent cells were removed, and biofilms were stained
with crystal violet. The relative amount of biofilm formation
was determined by solubilizing crystal violet in acetic acid and
determining optical density with a spectrophotometer.
Stimulation of bacterial adhesion to plastic by heparin was
observed over a range from 0.1 unit/ml to the maximum tested
dose of 1,000 units/ml (Fig. 1A). These are relevant levels as
the concentration of heparin used in catheter lock solution is
commonly up to 10,000 units/ml. Heparin, in the absence of
cells did not stimulate crystal violet staining of wells (data not
shown). We tested other heparin-like glycosaminoglycans and
anionic polysaccharides to determine if the effect is specific to
heparin and observed statistically significant biofilm stimula-
tion with the addition of sodium heparin, ammonium heparin
(P  0.01), and to a lesser degree heparan sulfate, chondroitin
sulfate B, and dextran sulfate, but not chondroitin sulfate C
(Fig. 1B). We also found that heparin-stimulated biofilms dis-
played antibiotic resistance levels indistinguishable from non-
stimulated biofilms, including highly elevated levels of vanco-
mycin resistance compared to planktonic cells (data not
shown) (42).
Biofilm formation in the presence and absence of heparin
was assessed over time using the microtiter plate assay. A
twofold increase in crystal violet staining was seen as early as
3.5 h; at 6 to 9 h approximately three times as much staining
was observed (see Fig. 1C).
The adherence of S. aureus to silicone elastomer coupons
was also determined. Silicone elastomer is a common compo-
nent of catheters. At 24 h, a twofold increase in adherence to
silicone elastomer coupons was recorded (0.11  0.04 A550
units for saline versus 0.25  0.09 A550 units for heparin, P 
0.05).
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Microscopic observation of heparin-stimulated biofilms. S.
aureus biofilms were allowed to form overnight on polyvinyl-
chloride under static conditions and then washed repeatedly
and prepared for scanning electron microscopy. Scanning elec-
tron microscopy images suggest that surface coverage and the
three-dimensional structure of biofilms were stimulated by
heparin at 1,000 U/ml (Fig. 2, panels A versus B).
Phase microscopy of heparin-treated biofilms formed on
polystyrene similarly reveal that heparin promotes biofilm for-
mation and that heparin-grown biofilms subject to shear forces
through repeated washes with PBS appeared to be more tena-
cious than those formed with control medium (Fig. 2, panels C
and D).
Epifluorescent staining of biofilms was also utilized to assess
the effect of heparin on biofilms. Syto-9, a quantitative DNA-
binding fluorescent dye, was used to determine relative
amounts of biofilm. Figure 2, panels C and D, depicts digital
micrographs of Syto-9-stained 4-hour biofilms taken with the
same exposure time. Heparin-treated biofilms were more
brightly stained and exhibited larger but not more numerous
microcolonies. When relative fluorescence was measured, we
reproducibly found a 2- to 10-fold increase in the heparin-
treated sample. In a sample experiment taken 5 hours after the
inoculation, we found a 3.5-fold increase in biofilm fluores-
cence in the heparin-treated sample [7.5  1010 1.1  1010
relative fluorescent units (RFU) for the heparin-treated strain
and 2.1  109 1.4  109 RFU for the control, n  5 fields, P
 0.01].
Biofilms are often characterized by the presence of an ex-
tracellular matrix. We used calcofluor, a fluorescent dye that
has been used to stain the extracellular matrix of biofilms in
other species, to determine whether heparin-treated biofilms
exhibit this hallmark of biofilm formation (Fig. 2 G and H)
(24). At 5 hours, biofilms formed with and without heparin
FIG. 1. Sodium heparin increases the adherence of S. aureus to polystyrene. A. Dose response. Serial dilutions of sodium heparin were added
to cultures and biofilms were allowed to form for 16 h, at which time nonadherent cells were removed by vigorous washing. Adherent cells were
stained with crystal violet. Spectrophotometric analysis of solubilized crystal violet is shown as a function of increasing sodium heparin concen-
tration in U/ml. B. Biofilm formation in response to various charged molecules and glycosaminoglycans. Microtiter biofilms were analyzed as above,
and significant differences from the saline-alone control are shown with an asterisk (P 0.01). C. Adherence kinetics. The effect of sodium heparin
(1,000 U/ml, 10% vol/vol) or saline (10% vol/vol) upon biofilm formation was assessed over time. A photograph of crystal violet-stained biofilms
is shown at the top of the panel and spectrophotometric results are charted with respect to time at the bottom of the panel. D. Growth curve. The
effect of heparin (1,000 U/ml) on planktonic growth in TSB plus glucose was analyzed and plotted versus time.
4598 SHANKS ET AL. INFECT. IMMUN.
FIG. 2. Sodium heparin enhances S. aureus biofilm formation. The effect of heparin on the formation of S. aureus MZ100 biofilms on abiotic
surfaces was assessed microscopically. Scanning electron micrographs of 12-hour-old S. aureus biofilms on polyvinylchloride are shown with (B) and
without (A) heparin (12,500 magnification, bar 	 10 m). S. aureus biofilms (4 h) formed on polystyrene were viewed with phase-contrast
microscopy (C and D, bar 	 20 m, the arrow indicates a phase-bright microcolony), or were stained with a fluorescent bacterial stain (Styo-9)
with a 250-ms exposure and at 400 magnification with epifluorescent microscopy (E, without heparin, and F, with heparin at 1,000 U/ml). The
5-hour-old biofilms were stained with calcofluor and viewed with epifluorescent microscopy at 100 magnification, with (H) and without
(G) heparin.
VOL. 73, 2005 HEPARIN STIMULATES S. AUREUS BIOFILMS 4599
both consisted of monolayers with little to no calcofluor stain-
ing interspersed with large phase-bright microcolonies that
stained brightly with calcofluor (Fig. 3). The relative fluores-
cence of several fields was quantified using Open Lab software.
A significant difference in brightness was observed from hep-
arin-treated biofilms at both 5 and at 21 hours; at 5 h the
average RFU/visual field was found to be 1.9  1010  3.3 
109 for heparin-treated biofilms versus 7.4  109  5.5  109
FIG. 3. Sodium heparin enhances S. aureus biofilm formation. The effect of heparin formation of S. aureus (MZ100) biofilms on abiotic surfaces
was assessed microscopically. S. aureus biofilms (4 hours) formed on polystyrene were viewed with phase 2 microscopy (A, without heparin, and
C, with heparin, the arrow indicates one of several phase-bright microcolonies), or were stained with a fluorescent bacterial stain (Styo-9) with a
250-ms exposure and at 400 magnification with epifluorescent microscopy (B, without heparin, and D, with heparin at 1,000 U/ml). The 5-h-old
biofilms were stained with calcofluor and viewed with phase 2 microscopy (E, without heparin, and G, with heparin, the arrow indicates a
macrocolony), or epifluorescent microscopy at 100 magnification, without (F) or with (H) heparin.
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for control biofilms (P  0.001, n  8 fields); data are not
shown for 21 h. Similar results were observed for Styo-9 at 4 h.
Observation of biofilms formed in the presence of heparin
(Fig. 2 B, D, F, and H) suggests that they have more three-
dimensional architecture than do biofilms grown with control
medium (Fig. 2A, C, E, and G and data not shown) and are
consistent with the microtiter plate analysis results that heparin
promotes biofilm formation.
Heparin does not promote S. aureus biofilm formation by
accelerating growth. Increased growth in the presence of the
polysaccharide heparin could account for the more robust bio-
films we observed. To determine whether sodium heparin stim-
ulates or impedes the growth of a S. aureus population, the
optical density of MZ100 cultures grown in TSB plus 0.2%
glucose in the presence of either saline or sodium heparin
(1,000 U/ml) was assessed over 24 h. Sonication was used to
disrupt any cell-cell interactions that could alter optical density
readings. Heparin at 1,000 U/ml had no discernible impact
upon the growth rate of S. aureus strain MZ100 (see Fig. 1D),
suggesting that it does not stimulate biofilm formation by ac-
celerating growth. The same results were found for cultures
grown without the addition of 0.2% glucose (data not shown).
Sodium heparin promotes cell-cell interactions but not pri-
mary attachment. Staphylococcal biofilm formation has been
divided into two developmental stages. Primary attachment is
the first stage, wherein cells form stable interactions with a
surface (22). This is followed by a growth and cell-cell inter-
action-dependent accumulation phase. We examined the effect
of sodium heparin on each stage of S. aureus biofilm formation.
Cells adherent to plastic were observed with phase-contrast
microscopy, and the foci were counted, with a single cell or a
group of associated cells counted as one focus. Heparin did not
affect primary attachment at 10 or 30 min (see Table 2).
Cell-cell interactions were assessed both in the planktonic
phase and on a plastic surface. Overnight planktonic cultures
were sonicated to disrupt the majority of existing cell-cell in-
teractions and then subcultured into TSB plus 0.2% glucose
with either heparin or saline added to 10% (vol/vol). Samples
were placed in 24-well dishes and incubated at 37°C without
shaking. Aliquots of cells were removed from the planktonic
phase of nonshaking cultures, observed microscopically, and
assessed for cell clustering over the course of 3 h. The fre-
quency of cell clusters of three or more bacteria was up to
fourfold greater for cells in the presence of heparin (Fig. 4A).
By 1 hour, 41% of microscopic foci from heparin-containing
cultures consisted of clusters of three or more cells, compared
to only 14% foci for cells grown without heparin. By 2 hours
heparin cultures exhibited 70% clustered foci compared to
19% foci in the saline control. Planktonic cells grown overnight
in heparin and incubated on a rapidly rotating wheel at 37°C
also exhibit elevated levels of clustered foci compared to a
no-heparin control (data not shown).
One potential caveat to the cell-cell interaction experiments
is the possibility that the clustered foci we observed were from
cells that failed to separate after division rather than derived
from cells that came in contact with each other and then
adhered. To address this possibility, two strains were mixed in
TSB plus 0.2% glucose with heparin (1,000 U/ml) and plasmid-
selective antibiotic, one with a plasmid-borne copy of dsred
(which codes for a red fluorescent protein) under the control
of a strong promoter and the other with a vector control. Using
epifluorescent microscopy, we observed at 3 h that more than
40% of clusters of three cells or more contained both red-
fluorescent and nonfluorescent cells, indicating that newly
formed cell-cell interactions do occur under these conditions,
in clusters of six or more cells more than 60% of clusters were
mixed (n 
 100, data not shown).
The cell-clustering phenotype was assessed in similar exper-
iments on a polystyrene surface. We found that heparin medi-
ates cell-cell adherence on the surface in a manner similar to
that observed for planktonic cells (Fig. 3B). We also deter-
mined surface coverage by S. aureus in the presence and ab-
sence of heparin as described in Materials and Methods and
found that heparin was associated with more surface coverage
at 2 h (22% coverage with heparin, 11% without, P 0.05) and
3 h (29% with heparin, 19% without, P  0.05) but not at 30
min (2.7% with heparin, 3.6% without, P 
 0.05).
Effect of a protein synthesis inhibitor on heparin-dependent
cell-cell interactions. The observed delay in elevated levels of
cell-cell interactions and surface coverage in the presence of
heparin raised the question of whether the effect of heparin in
this system is dependent on protein synthesis. Chlorampheni-
col at 30 g/ml was added to cells in the presence or absence
of heparin (1,000 U/ml heparin or saline in TSB plus 0.2%
glucose) to inhibit protein synthesis. It is formally possible that
TABLE 1. Strains and plasmids used
Strain or
plasmid Description
Reference or
source
Strains
MZ100 Wild type Microbia, Inc.
ALC2713 MZ100 agr::tetM This study
SMC2714 MZ100 icaADBC::tetK This study
SMC2715 MZ100 hla::ermC This study
ALC4007 MZ100 sarA::aph3-A This study
ALC3741 MZ100 sigB::ermC This study
8325-4 Wild type 58
SMC1017 8325-4 hla::ermC 46
RN4220 Wild type, DNA acceptor strain 44
Sa113 Wild type, DNA acceptor strain 29
SMC1441 Sa113 ica::tetK 12
SH1000 Wild type 27
ALC3085 SH1000 sigB::ermC This study
Plasmids
pALC2201 Promoter of asp23 driving gfpuv 56
pALC1743 RNAIII promoter regulating gfpuvr 2
pALC2111 dsred replacing gfpuvr on pALC1743 This study
pSC23 pBT5 with icaADBC::tetK 12
TABLE 2. Heparin does not promote primary cell
surface attachment
Strain Treatment
Avg no. of focia  SD
10 min 30 min
MZ100 Saline 210.7  9.5 537.3 35.8
MZ100 Heparinb 214  19.6 549.3 42.4
a The average of three microscope fields is shown, n 
 630 foci per group at
10 min and 
1,600 at 30 min.
b Sodium heparin was used at 1,000 U/ml in TSB with 0.2% glucose.
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the kinetics of cell-cell interactions would be different in the
experimental samples because cell number would not increase
over time. Therefore, a double inoculum of cells (4  107
cells) was added to the samples containing chloramphenicol as
a control for final cell number, because we had previously
determined this was the approximate change in cell number at
3 h when samples were taken to assess cell clustering. We
found that cells in which protein synthesis was inhibited by
chloramphenicol did not demonstrate a heparin-dependent in-
crease in cell-cell interactions at 180 min (Fig. 3C). The lack of
this increase in cell-cell interactions suggests that heparin does
not directly mediate cell-cell interactions.
Influence of sodium heparin on sigma B activity. One pos-
sible mechanism for the effect of heparin in stimulating biofilm
formation is that cells treated with heparin could be stressed
without an obvious change in growth rate. Such stress might
lead to stimulation of biofilm formation as has been demon-
strated for high levels of ethanol and sodium chloride. Sigma B
is a sigma factor that activates an array of genes in response to
cellular stress (6). Sigma B activity correlates with cellular
stress and has been implicated in staphylococcal biofilm for-
mation (34, 35, 53).
A transcriptional fusion of gfp to a sigma B-dependent pro-
moter (asp23) was employed to investigate whether heparin
stimulates a stress response (20). For this experiment we uti-
lized strain SH1000, known to be wild type for sigB regulation
(34). Strain MZ100 is known to have a deletion in the sigB
regulatory gene rsbU so it is inappropriate for studying sigB
expression and activity (20, 34). SH1000 and an isogenic sigB
mutant strain were transformed with a plasmid-borne asp23-
gfp reporter construct (27, 34). Cells were grown in TSB plus
0.2% glucose with sodium heparin (1 to 1,000 U/ml) or saline.
Expression of asp23 was then determined using a fluorometer.
No change in asp23 transcription with respect to heparin was
observed in SH1000 (3,857 RFU without heparin and 3,889
RFU with heparin at 100 U/ml, data not shown). Similarly,
heparin caused no change in sigma B activity in two clinical
isolates transformed with the asp23-gfp reporter construct
(data not shown). sigB mutants of SH1000 displayed low GFP
levels compared to the wild-type SH1000 (for example, at 1
U/ml of heparin, the sigB mutant had 61 RFU and the wild
type had 3,533 RFU).
A role for sigma B in heparin-dependent biofilm formation
was further tested genetically. We hypothesized that if compo-
nents of the sigma B regulon were responsible for increased
bacterial attachment in the presence of heparin, then sigB
mutants would not display increased attachment with the ad-
dition of heparin. Consistent with another report (63), a sigB
mutation in MZ100 did not adversely affect biofilm formation,
nor did it reduce PIA levels (data not shown). However, we
observed that a sigB mutation in the SH1000 background con-
ferred a 70 to 80% reduction in biofilm formation that was
partially rescued by heparin. In one representative experiment
where biofilms were allowed to form for 8 h, heparin stimu-
lated a 92% increase in biofilm formation in the sigB mutant
and a similar increase for SH1000 (68%, P  0.05).
Sodium heparin enhances biofilm formation of known bio-
film mutants. We hypothesized that if known biofilm-related
factors were responsible for increased bacterial attachment in
the presence of heparin, strains with mutations in these factors
would not display increased attachment with the addition of
heparin. To this end we tested agr, hla, and sarA mutants for
biofilm formation in the presence and absence of heparin using
the microtiter dish assay (Fig. 5A). In the absence of heparin,
FIG. 4. Heparin indirectly stimulates S. aureus cell-cell interac-
tions. The effect of heparin on cell-cell interactions was assessed using
phase-contrast microscopy with strain MZ100. Foci were counted and
classified as either clusters (3 cells/focus) or nonclusters (1 or 2 cells
per focus). A. Planktonic-phase clustering: aliquots were removed at
the times indicated, viewed microscopically, assessed for cell-cell in-
teractions, and plotted as percent of foci in clusters as a function of
time (n 	 1,492 foci). B. Surface clustering: cells attached to a poly-
styrene surface were microscopically assayed (n 	 18,632 foci). The
percent of foci in clusters are plotted as a function of time. C. Clus-
tering without protein synthesis: a planktonic culture was treated as
above except that chloramphenicol (30 g/ml) was added to inhibit
protein synthesis. A double inoculum of cells was added at the onset of
the experiment to cultures exposed to chloramphenicol to control for
the difference in cell number that could affect the frequency of cell-cell
interactions. At 180 min, samples from four wells per category were
assessed microscopically for cell-cell interactions (n 	 2,025 foci).
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these mutants behaved as previously described when we tested
them in the MZ100 background (3, 8, 63, 65, 66). Mutation of
the gene that codes for the staphylococcal accessory regulator,
sarA (9), severely reduced biofilm formation (P  0.01) and
was almost completely rescued by the addition of exogenous
heparin at 1,000 U/ml to wild-type levels without heparin (P 
0.01, Fig. 5A). We found that an agr mutation in the MZ100
background confers a hyperbiofilm phenotype that was further
enhanced by heparin (P  0.01). Mutation of the hla gene,
which codes for alpha-toxin, confers a biofilm-defective phe-
notype (P  0.01) in MZ100 that was completely rescued by
heparin (P  0.01).
In addition to the microtiter dish assay we directly observed
3- to 5-hour biofilms with phase microscopy and fluorescent
microscopy. To quantify the microscopic data we stained cells
with Syto-9, a quantitative fluorescent stain that binds to DNA,
and measured the relative fluorescence of several fields of view
for each strain. These results closely mirror these found with
the microtiter plate assay (data not shown).
S. aureus has adhesins on its surface that enable it to bind to
a number of proteins, such as fibrinogen and fibronectin. These
adhesins may have a role in heparin-stimulated biofilm forma-
tion. We tested whether some of these surface adhesins are
necessary for heparin-dependent biofilm stimulation after 24 h
of incubation. ClfA and ClfB are surface molecules that help S.
aureus bind to fibrinogen (40, 43). We determined whether clfA
clfB double mutants were stimulated in biofilm formation by
heparin using the microtiter dish assay. In the 8325-4 back-
ground, the wild type had an A550 reading at 24 h of 0.26 
0.017 with saline and 2.67  0.225 with heparin, and the clfA
clfB double mutant was also stimulated by heparin (0.15 0.21
with saline and 1.58  0.18 with heparin). We observed a
similar pattern with a clfA clfB double mutant in the Newman
strain background (0.16 0.22 with saline and 1.34 0.22 with
heparin).
S. aureus binds to fibronectin via the large surface proteins
FnbA and FnbB (18, 32). We found that fnbA and fnbB mu-
tants were stimulated in adherence by heparin. SH1000 strains
with fnbA and fnbB mutations exhibited an increase in A550
reading from 0.18 0.02 with saline to 2.16 0.2 with heparin
for fnbA and from 0.2  0.03 in saline to 1.4  0.15 with
heparin for fnbB.
Heparin stimulates biofilms independently of polysaccha-
ride intercellular adhesin. Polysaccharide intercellular adhesin
is produced by the icaADBC gene products and is a well-
characterized factor involved in staphylococcal biofilm forma-
tion (22, 38, 41, 45). Staphylococcal strains with ica mutations
are reported to form poor biofilms in which primary attach-
ment is unaffected but later stages of biofilm formation are
impeded (39). In addition, cultures of S. aureus containing
episomal copies of the ica locus exhibit enhanced biofilm for-
mation, suggesting that elevated levels of PIA are sufficient to
FIG. 5. Effect of heparin on known biofilm formation mutants. A. Mutants (gene names noted) were assessed for biofilm formation in the
microtiter dish assay (8-h biofilms) with heparin at 1,000 U/ml (shaded bars) or with saline (white bars). B. Relative PIA levels were determined
in response to heparin at 1,000 U/ml. Tenfold serial dilutions of protease-treated whole-cell lysates were immunoblotted with anti-PIA antibodies.
C. Isogenic pairs of wild-type and ica mutants in the MZ100 and Sa113 backgrounds were assessed for biofilm formation in the microtiter dish assay
(9-h biofilms). One asterisk signifies statistical significance (P  0.05) between a wild-type strain and its isogenic mutant strain without heparin;
two asterisks signify statistical significance (P  0.05) between strains with and without heparin.
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stimulate biofilm formation (12). Therefore, we tested whether
heparin enhances biofilm formation through increased PIA
levels.
Levels of PIA from cells grown to the stationary phase in the
presence or absence of heparin (1,000 U/ml) were assayed
biochemically (Fig. 5B). PIA antibodies were used to probe a
dilution series of cell lysates. An isogenic ica deletion strain
was generated for use as a negative control. PIA levels were
indistinguishable for cells grown in the presence and absence
of heparin (Fig. 5B).
The dependence of biofilm formation on PIA was also tested
genetically. Biofilm formation of isogenic ica and wild-type
strains was tested in the presence and absence of heparin. We
found that deletion of the ica operon in MZ100 conferred no
significant reduction in biofilm formation (P 	 0.43) as has
been reported in some strain backgrounds (4) (Fig. 5C). Hep-
arin stimulated biofilm formation by both MZ100 and its ica
derivative. Therefore, we performed the analysis in strain
Sa113, where the ica locus has been shown to be important in
biofilm formation (12). ica mutants in the Sa113 background
were significantly reduced in biofilm formation (P  0.01) and
were completely rescued by heparin (Fig. 5C). The observa-
tions that an icamutant strain can form robust biofilms in the
presence of heparin and that PIA levels are not altered are
consistent with heparin stimulating biofilm formation indepen-
dently of PIA.
Heparin affects biofilms formation of other S. aureus strains
and other staphylococcal species. Since there can be major
phenotypic differences between S. aureus strains, the effect of
heparin on several strains was tested. We found that heparin
stimulated biofilm formation in seven of seven laboratory
strains tested (Col, Newman, MZ100, RN4220, SH1000,
8325-4, and Sa113; the last five are closely related). The in-
crease in biofilm formed in the presence of heparin versus an
equal volume of saline ranged from 80 to 800% when assessed
by the 96-well plate biofilm assay (data not shown). Eight out
of eight S. aureus clinical isolates also exhibited increased bio-
film formation in the presence of heparin (data not shown).
Staphylococcus saprophyticus is a source of urinary tract in-
fections. Heparin had no discernible effect upon biofilm for-
mation in the one strain of S. saprophyticus tested. One of three
Staphylococcus epidermidis strains tested (strain O-47) (25) had
a biofilm more than 200% greater with heparin than with saline
when assessed by the microtiter plate biofilm assay. Strain
ATCC R97-03 exhibited less than half of the biofilm formed in
saline, and ATCC R94-10 had a slight reduction in biofilm
formation in the presence of heparin (data not shown).
DISCUSSION
The data presented here demonstrates that sodium heparin,
a common catheter lock solution, stimulates S. aureus biofilm
formation on abiotic surfaces when present in growth medium.
We show that heparin enhances adherence to polystyrene in a
dose-dependent manner and that the kinetics of adherence are
positively affected. Although heparin is a heterogeneous poly-
saccharide, the stimulation of biofilm formation is not a simple
consequence of more biomass, as the growth rate is not accel-
erated in the presence of this compound. The stage in biofilm
formation at which heparin acts appears to be after primary
attachment and is likely a result of increased cell-cell interac-
tions. However, heparin was able to bypass the biofilm defect
of mutations in genes reported to negatively impact the early
stage (sarA and ica) and later stages (hla) of biofilm formation
(8, 39, 63). These data suggest that S. aureus has multiple
routes to build a biofilm and are consistent with but do not
prove that heparin stimulates biofilm formation through a
novel pathway or by activating an uncharacterized mechanism
downstream of sarA/agr.
Strains with mutations in the agr quorum-sensing system
form very robust biofilms compared to the wild type. We hy-
pothesized that heparin may stimulate biofilm formation by
inhibition of agr expression or Agr activity. The result that agr
mutants are further stimulated by heparin indicates that the
heparin-associated biofilm stimulation effect does not act
through inhibiting agr expression or function.
Heparin increased the frequency of clumped cells in the
planktonic phase and on polystyrene. The loss of clustering
with the addition of chloramphenicol implies that this pheno-
type is dependent upon protein synthesis. Moreover, the addi-
tion of exogenous heparin does not act immediately as a cross-
bridge between cocci. These data suggests that heparin
stimulates the formation of adhesion molecules that make S.
aureus better able to adhere to one another in either a heparin-
dependent (where heparin acts as a cross-bridge) or heparin-
independent manner. Consistent with this hypothesis, several
groups have evidence suggesting that S. aureus codes for a
heparin binding protein (14, 16, 37). Pascu and colleagues
found that 30 of 38 coagulase-negative staphylococci were able
to aggregate to heparin-coated beads and this binding was
inhibited by several sulfated molecules (48). Another report
showed the presence of heparin binding proteins on the sur-
face of Neisseria gonorrhoeae, Helicobacter pylori, S. epidermi-
dis, S. aureus, Staphylococcus pyogenes, and two species of Yer-
sinia (14). The identity of the gene(s) that codes for the factor
responsible for heparin binding activity has not been reported.
We show that heparin stimulates biofilm formation on abi-
otic surfaces, but do these biofilms display the characteristics
reported for S. aureus biofilms? The observation that heparin-
exposed biofilms form microcolonies and macrocolonies that
are stained by calcofluor is consistent with typical biofilm for-
mation. Additionally, we found that nonstimulated biofilms
and heparin-stimulated biofilms had high levels of resistance to
the antibiotic vancomycin; overnight biofilms from both exhib-
ited a 64-fold increase in minimum bactericidal concentration
compared to planktonic cells (data not shown).
The increase in cell-cell interactions and adherence to sur-
faces of S. aureus exposed to heparin may be part of a normal
physiological response this pathogenic species has evolved to
respond to the host environment. When an S. aureus cell con-
tacts the epithelial cell matrix, it would naturally be exposed to
glycosaminoglycans, and it could benefit the bacteria to re-
spond to this signal by making adhesive molecules allowing it
to maintain itself in a potentially beneficial niche. Consistent
with this idea, several pathogenic microorganisms (bacteria,
viruses, and eukaryotic parasites) have evolved ways to bind to
heparin to mediate attachment to or internalization into mam-
malian cells (14, 15, 49). Other organisms, including gram-
positive bacteria such as Listeria monocytogenes and Strepto-
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coccus pyogenes, utilize heparin and related glycosaminoglycans
to facilitate interaction with mammalian cells (15, 26, 57).
Future studies more closely mimicking the clinical setting as
well as clinical experiments should be performed to determine
whether heparin promotes persistent bacterial infections. Ad-
ditionally, alternative lock solutions should be and are being
tested both in the laboratory and in clinical settings (7, 52, 55,
59, 64).
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